(Q37452740)

20 August 2017

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes (English)

1 reference

20 August 2017

0 references

1

Ethan Basch

1 reference

20 August 2017

8

Alexia Iasonos

1 reference

20 August 2017

Xiaoyu Jia

2

1 reference

20 August 2017

Glenn Heller

3

1 reference

20 August 2017

Allison Barz

4

1 reference

20 August 2017

Laura Sit

5

1 reference

20 August 2017

Michael Fruscione

6

1 reference

20 August 2017

Mark Appawu

7

1 reference

20 August 2017

Thomas Atkinson

9

1 reference

20 August 2017

Shari Goldfarb

10

1 reference

20 August 2017

Ann Culkin

11

1 reference

20 August 2017

Mark G Kris

12

1 reference

20 August 2017

Deborah Schrag

13

1 reference

20 August 2017

language of work or name

English

0 references

publication date

17 November 2009

1 reference

Journal of the National Cancer Institute

20 August 2017

1 reference

20 August 2017

101

1 reference

20 August 2017

23

1 reference

20 August 2017

1624-1632

1 reference

The prognostic significance of patient-reported outcomes in cancer clinical trials

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient-reported outcomes and the evolution of adverse event reporting in oncology

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient-reported outcomes supporting anticancer product approvals

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

The regulation of patient-reported outcome claims: need for a flexible standard

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

EQ-5D: a measure of health status from the EuroQol Group

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

FDA turns to electronic "sentinel" to flag prescription drug safety problems

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Patient online self-reporting of toxicity symptoms during chemotherapy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786917

The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy

2 September 2018

1 reference

12 December 2020

Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group

1 reference

12 December 2020

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

12 December 2020

Quality of life assessment. An independent prognostic variable for survival in lung cancer

1 reference

12 December 2020

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group

1 reference

12 December 2020

Asking the Community About Cutpoints Used to Describe Mild, Moderate, and Severe Pain

1 reference

12 December 2020

Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Mild, moderate, or severe pain categorized by patients with cancer with bone metastases

1 reference

12 December 2020

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

1 reference

12 December 2020

Evaluation of Serious Adverse Drug Reactions

1 reference

12 December 2020

Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJP386

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19920223

1 reference